|
ABDOLLAH FBRIGANTI ASUARDI NCASTIGLIONE FGALLINA ACAPITANIO UMONTORSI F: "metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypotheses etiology, and prevention", KOREAN J UROL., vol. 52, no. 8, August 2011 (2011-08-01), pages 507 - 16
|
|
ALBERTO BRIGANTIUMBERTO CAPITANIONAZARENO SUARDIANDREA GALLINAANDREA SALONIAMARCO BIANCHIMANUELA TUTOLOVALERIO DI GIROLAMOGIORGIO : "Benign prostatic hyperplasia and its Aetiologies", EUROPEAN UROLOGY SUPPLEMENTS, vol. 8, no. 13, December 2009 (2009-12-01), pages 865 - 871
|
|
AZIMI HANIEH ET AL: "A Review of Animal and Human Studies for Management of Benign Prostatic Hyperplasia with Natural Products: Perspective of New Pharmacological Agents", INFLAMMATION & ALLERGY DRUG TARGETS, BENTHAM SCIENCE PUBLISHERS, NL, vol. 11, no. 3, 1 June 2012 (2012-06-01), pages 207 - 221, XP009180305, ISSN: 1871-5281, DOI: 10.2174/187152812800392715
*
|
|
BAEUERLE, P.A.BALTIMORE, D.: "NF- : ten years after", CELI, vol. 87, 1996, pages 13 - 20, XP000962411, DOI: 10.1016/S0092-8674(00)81318-5
|
|
BANACH M.SERBAN C.ARONOW W.S.RYSZ J.DRAGAN S.LERMA E.V.APETRII M.COVIC A.: "Lipid, blood pressure and kidney update 2013", INT. UROL. NEPHROL., vol. 46, 2014, pages 947 - 961
|
|
BAYNE C.W.DONNELLY F.ROSS M.HABIB F.K.: "Serenoa repens (Permixon): A 5alpha-reductase types I and II inhibitor-new evidence in a cucture model of BPH", PROSTATE, vol. 40, 1999, pages 232 - 241
|
|
BERG, P.A.DANIEL, P.T.: "effects of flavonoid compounds on the immune response", PROG. CLIN. BIOL. RES., vol. 280, 1988, pages 157 - 171
|
|
BISWAS S.K.: "Does the interdependency between oxidative stress and inflammation explore the Antioxidant Paradox?", OXID. MED. CELL. LONGEV. 2016, 2016, pages 5698931
|
|
BOBE GALBERT PSSANSBURY LB ET AL.: "INTERLEUKIN-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the poly prevention trial", CANCER PREV RES (PHILA, vol. 3, 2010, pages 764 - 75
|
|
BONVIVITE G.MINUTOLI L.MORGIA G.BITTO A.POLITO F.IRRERA N.MARINI H.SQUADRITO F.ALTAVILLA D.: "Effect of Serenoa repens, lycopene, and selenium on inflammatory phenotype activation: An in vitro and in vivo comparison study", UROLOGY, vol. 77, no. 248, 2011, pages e249 - e216
|
|
BORRELLI, F.MAFFIA, P.PINTO, L.LANARO, A.RUSSO, A.CAPASSO, F.LALENTI, A.: "Phytochemical compounds involved in the antiinflammatory effect of propolis extract", PHYTOTHERAPY, vol. 73, 2002, pages S53 - S63, XP002669338, DOI: 10.1016/S0367-326X(02)00191-0
|
|
BRIGANTI, A.CAPITANIO, U.SUARDI, N.GALLINA, A.SALONIA, A.BIANCHI, M.TUTOLO, M.GIROLAMO, V.DI, GUAZZONI, G.RIGATTI, P.: "Benign prostatic hyperplasia and its aetiologies", EUR. UROL., vol. 8, 2009, pages 865 - 871
|
|
BY SILVERIO F.MONTI S.SCIARRA A.VARASANO P.A.MARTINI C.LANZARA S.D'ERAMO G.NICOLA S.TOSCANO V.: "Effects of long-term treatment with Serenoa repens (Pennixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia", PROSTATE, vol. 37, 1998, pages 77 - 83, XP009143666
|
|
CARTER, H.B.MORRELL, C.H.PEARSON, J.D.BRANT, L.J.PLATO, C.C.METTER, E.J.CHAN, D.W.FOZARD, J.L.WALSH, P.C.: "Estimation of prostatic growth using serial progesspecific antigen measurements in men with and without prostate disease", CANCER RES., vol. 52, 1992, pages 3323 - 3328
|
|
CHIANG, L.C.NG, L.T.CHIANG, W.CHANG, M. Y.LIN, C.: "Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species", PLANT MED., vol. 69, 2003, pages 600 - 604
|
|
CHIRUMBULO S: "The role of quercetin, flavonols and flavones in modulating inflammatory cells function", INFLAMM ALLERGY DRUG TARGETS, vol. 9, 2010, pages 263 - 85
|
|
CHUANG CCMARTINEZ KXIE G ET AL.: "Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{ alpha}-mediated inflammation and insulin resistance in primary human adipocytes", AM J CLIN NUTR, vol. 92, 2010, pages 1511 - 21
|
|
COMALADA, M.CAMUESCO, D.SIERRA, S.BALLESTER, I.XAUS, J.GALVEZ, J.ZARZUELO, A.: "In vivo anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway", EUR. J. IMMUNOL., vol. 35, 2005, pages 584 - 592, XP055189739, DOI: 10.1002/eji.200425778
|
|
DATABASE WPI Week 201631, Derwent World Patents Index; AN 2016-150611, XP002798987
*
|
|
DD BALAVOINEYV DELETED: "Peroxynitrite digging by different antioxidants. Part I: Convenient assay", NITRIC OXIDE, vol. 3, 1999, pages 40 - 54
|
|
DE NUNZIO, C.KRAMER, G.MARBERGER, M.MONTIRONI, R.NELSON, W.SCHRONDER, F.SCIARRA, A.TUBARO, A.: "The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation", EUR. UROL., vol. 60, 2011, pages 106 - 117, XP028223808, DOI: 10.1016/j.eururo.2011.03.055
|
|
DENG, L.ZONG, W.TAO, X.LIU, S.FENG, Z.LIN, Y.CHEN, M.: "Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angusifolium L", JOURNAL OF ETHNOPHARMACOLOGY, vol. 232, 2019, pages 1 - 10
|
|
DU TOIT, K.BUTHELEZI, S.BODENSTEIN, J.: "Anti-inflammatory and antibacterial profiles of selected compounds found in South African propolis", S. AFR. J. SKIING, vol. 105, 2009, pages 470 - 472
|
|
DUCREY, B.MARSTON, A.GOHRING, S.HARTMANN, R.W.HOSTETTMANN, K.: "Inhibition of 5a-reductase and aromatase by the ellagitannins ooenothein A and ooenothein B from Epilobium species", MED PLANT., vol. 63, 1997, pages 111 - 114
|
|
EL-GAMMAL, A.A.MANSOUR, R.M.: "Antimicrobial activities of some flavonoid compounds", ZENTRALBL. MIKROBIOL., vol. 141, 1986, pages 561 - 565, XP009097386
|
|
GARCIA-LAFUENTE, A.GUILLAMON, E.VILLARES, A.ROSTAGNO, M.A.MARTINEZ, J.A.: "Flavonoids as anti-inflammatory agents: complications in cancer and cardiovascular disease", INFLAMM. RES., vol. 58, 2009, pages 537 - 552, XP019732153, DOI: 10.1007/s00011-009-0037-3
|
|
GONZALEZ-SEGOVIA, R.QUINTANAR, J.L.SALINAS, E.CEBALLOSSALAZAR, R.VILES-JIMENEZ, F.TORRES-LOPEZ, J.: "Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig", J. GASTROENTEROL., vol. 43, 2008, pages 441 - 447, XP019632715
|
|
GREGOIRE ROBERTABAURELIEN DESCAZEAUDACYVES ALLORYADFRANCIS VACHEROTAALEXANDREDE LA TAILLE: "Should We investigate Prostate inflammation for the Management of benign prostatic hyperplasia?", EUROPEAN UROLOGY SUPPLEMENTS, vol. 8, no. 13, December 2009 (2009-12-01), pages 879 - 886
|
|
GUARD, T.ROTELLI, A.E.JUAREZ, A.O.PELZER, L.E.: "Antiinflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on advuvant arthritis in rat.", DRUG, vol. 56, 2001, pages 683 - 687
|
|
HAMALAINEN, M.NIEMINEN, R.VUORELA, P.HEINONEN, M.MOILANEN, E.: "Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NFkappaB activities, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitor effect in NOS activation and activation in no", MEDIATORS INFLAMM., 2007, pages 45673
|
|
HEINZ, S.A.HENSON, D.A.AUSTIN, M.D.JIN, F.NIEMAN, D.C.: "quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial", PHARMACOL. RES., vol. 62, 2010, pages 237 - 242, XP027112092
|
|
HEINZ, S.A.HENSON, D.A.NIEMAN, D.C.AUSTIN, M.D.JIN, F.: "A 12-week supplementation with quercetin does not affect natural killer celi activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects", BR. J. NUTR., 2010, pages 1 - 9
|
|
JOHNYELKAHWAJI: "Research and Reports in Urology", vol. 5, GENITOURINARY ONCOLOGY RESEARCH LABORATORY, article "The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer"
|
|
KONG, X.LIU, C.ZHANG, C.ZHAO, J.WANG, J.WAN, H.ZHU, H.ZHANG, P.CHEN, W.XIAO, Y.: "The suppressant effects of Saposhnikovia divaricata (Fangfeng) chromon extract on rheumatoid arthritis via inhibition of nuclear factor- and mitogen activated proteinases activation on collagen-induced arthritis model", J. ETHNOPHARMACOL., vol. 148, 2013, pages 842 - 850
|
|
KRAMER G1MARBERGER M: "Could inflammation be a key component in the progression of benign prostatic hyperplasia?", CURR OPIN UROL., vol. 16, no. 1, January 2006 (2006-01-01), pages 25 - 9
|
|
KRAMER GMITTEREGGER DMARBERGER M: "Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?", EUR UROL., vol. 51, no. 5, May 2007 (2007-05-01), pages 1202 - 16, XP029875250, DOI: 10.1016/j.eururo.2006.12.011
|
|
KUMAZAWA, Y.KAWAGUCHI, K.TAKIMOTO, H.: "Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha", CURR. PHARM. DES., vol. 12, 2006, pages 4271 - 4279, XP008097951, DOI: 10.2174/138161206778743565
|
|
LEE SANG-HUN ET AL: "The Antihyperplastic Effect of Oral Curcuma longa Ingestion in a Rat Model of Benign Prostatic Hyperplasia", THE KOREAN SOCIETY FOR ORIENTAL INTERNAL MEDICINE, KOREAN INTELLECTUAL PROPERTY OFFICE, vol. 30, no. 2, 30 June 2009 (2009-06-30), pages 355 - 364, XP053015010, ISSN: 1226-9174
*
|
|
LEE SKIM YJKWON S ET AL.: "Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells", BMB REP, vol. 42, 2009, pages 265 - 70
|
|
LIL A.LIBON C.TEMPLIER M.JUNQUERO D.LANTOINE-ADAM F.NGUYEN T.: "The expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1", IN VITRO. BJU INT., vol. 110, 2012, pages E301 - E307
|
|
LOKE, W.M.PROUDFOOT, J.M.HODGSON, J.M.MCKINLEY, A.J.HIME, N.MAGAT, M.STOCKER, R.CROFT, K.D.: "Specific dietary polyphenols attenuated atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction", ARTERIOSCLER. THROMB. HIDE BIOL., vol. 30, 2010, pages 749 - 757
|
|
MADERSBACHER SPONHOLZER ABERGER IMARSZALEK M: "Medicai Management of BPH: Role of plant extracts", EBU UPDATE SERIES EAU, vol. 5, 2007, pages 197 - 205, XP022210172, DOI: 10.1016/j.eeus.2007.04.004
|
|
MARTINON FPETRILLI VMAYOR ATARDIVEL ATSCHOPP J: "Gout-associated urie acid crysals activate the NALP3 inflammasome", NATURE, vol. 440, no. 7081, 9 March 2006 (2006-03-09), pages 237 - 41
|
|
MCLAREN, I.D.JERDE, T.J.BUSHMAN, W.: "Role of interleukins, IGF and stem cells in BPH", DIFFERENTIATION, vol. 82, 2011, pages 237 - 243, XP028296997, DOI: 10.1016/j.diff.2011.06.001
|
|
MENON V.P.SUGHEER A.R.: "Antioxidant and anti-inflammatory properties of curcumin", ADV. EXP. MED. BIOL., vol. 595, 2007, pages 105 - 125
|
|
MIDDLETON, E. JR.: "Effect of plant flavonoids on immune and inflammatory cell function", ADV. EXP. MED. BIOL., vol. 439, 1998, pages 175 - 182
|
|
NICKEL, J.C.: "Role of prostate inflammation in the clinical presentation of benign prostatic hyperplasia", EUR. UROL., 2015, pages e1459 - e1463
|
|
PANAHI Y.ALISHIRI G. H.PARVIN S.SAHEBAR A.: "Mytigation of systemic oxidative stress by curcuminoids in osteoarthritis: Results of a randomized controlled trial", J. DIET., vol. 13, 2016, pages 209 - 220
|
|
PAUBERT-BRAQUET M.MENCIA HUERTA J.M.COUSSE H.BRAQUET P.: "Effect of the lipid lipid-sterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils", PROSTAGLANDINS LEUKOT. ESSENT. FAT. ACIDS., vol. 57, 1997, pages 299 - 304
|
|
PEN G1FIBBI BAMUCHASTEGUI SCOSSETTI CAQUILANO FLAVERNY GGACCI MCRESCIOLI CMAGGI MADORINI L: "Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immune-mediated inflammation", J IMMUNOL., vol. 182, no. 7, 1 April 2009 (2009-04-01), pages 4056 - 64
|
|
RAYNAUD J.P.COUSSE H.MARTIN P.M.: "Inhibition of type 1 and type 2 5alpha-reductase activity by free factor acids, active ingredients of Permixon", J. STEROID BIOCHEM. MOL. BIOL., vol. 82, 2002, pages 233 - 239
|
|
RIAL, M.J.: "The link between benign prostatic hyperplasia and inflammation", EUR. UROL., 2013, pages 103 - 109
|
|
ROBERT, G.DESCAZEAUD, A.ALLORY, Y.VACHEROT, F.DE LA TAILLE, A.: "Should we investigate prostatic inflation for the management of benign prostatic hyperplasia?", EUR. UROL. SUPPL., vol. 8, 2009, pages 879 - 886
|
|
ROTELLI, A.E.GUARD, T.JUAREZ, A.O.DE LA ROCHA, N.E.PELZER, L.E.: "Comparative study of flavonoids in experimental models of inflammation", PHARMACOL. RES., vol. 48, 2003, pages 601 - 606, XP002551090, DOI: 10.1016/S1043-6618(03)00225-1
|
|
SAIL NAVARRETE R.GARCIA CARDOSO J.V.BARAT A.MANZARBEITIA F.LOPEZ FARRE A.: "BPH and inflammation: Pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay", EUR. UROL., vol. 44, 2003, pages 549 - 555
|
|
SERAFINI, M.PELUSO, I.RAGUZZINI, A.: "Flavonoids as antiinflammatory agents", NUTR JOB SOC., vol. 69, 2010, pages 273 - 278
|
|
SONG, Y.MANSON, J.E.BURING, J.E.SEX, H.D.LIU, S.: "Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: A prospective study and cross-sectional analysis", J. AM. COLI. NUTR., vol. 24, 2005, pages 376 - 384
|
|
TERAO J.: "Dietary flavonoids as antioxidants", FORUM NUTR, vol. 61, 2009, pages 87 - 94
|
|
TORMAKANGAS, L.VUORELA, P.SAARIO, E.LEINONEN, M.SAIKKU, P.VUORELA, H.: "In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model", BIOCHEM. PHARMACOL., vol. 70, 2005, pages 1222 - 1230, XP005060714, DOI: 10.1016/j.bcp.2005.07.012
|
|
VITALONE, A.ALLKANJARI, O.: "Epilobium spp.: Pharmacology and Phytochemistry", PHYTHER. RES., vol. 32, 2018, pages 1229 - 1240
|
|
WANG, L.YANG, J.R.YANG, L. Y.LIU, Z.T.: "Chronic inflammation in benign prostatic hyperplasia: complications for therapy", MED. HYPOTHESES, vol. 70, 2008, pages 1021 - 1023, XP022540247, DOI: 10.1016/j.mehy.2007.08.022
|
|
WU, C.H.WU, C.F.HUANG, H.W.JAO, Y.C.YEN, M.C.: "naturally occurring flavonoids attenuated high glucose-induced expression of inflammatory cyines in human monocytotic THP-1 cells", MOL. NUTR. FOOD RES., vol. 53, 2009, pages 984 - 995
|
|
WU, X.OJ, Y.LI, L.: "The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and sweriamarin in testosterone-induced benign prostatic hyperplasia in rats", TOXICOL. LETTER, vol. 265, 2017, pages 9 - 16, XP029854976, DOI: 10.1016/j.toxlet.2016.11.011
|
|
YANG, X.YUAN, L.XIONG, C.YIN, C.RUAN, J.: "Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulatory inflammatory responses, reducing oxidative stress and anti-proliferative", J. ETHNOPHARMACOL., vol. 157, 2014, pages 105 - 113
|